Skip to main navigation Skip to search Skip to main content

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study with and Open-label Extension Period to Evaluate the Efficacy and Safety of Telitacicept in Patients with Generalized Myasthenia Gravis

Project: Research

Project Details

StatusActive
Effective start/end date04/7/26 → 03/31/28

Funding

  • Pharmaceutical Research Associates Incorporated: $6,604.00